(Q37051466)

17 August 2017

1 reference

title

Renal protection: are all antihypertensive drugs comparable? (English)

1 reference

17 August 2017

Rashida Blake

1

1 reference

17 August 2017

Leopoldo Raij

series ordinal

2

1 reference

17 August 2017

Ivonne Hernandez Schulman

series ordinal

3

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Current Hypertension Reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

373-379

1 reference

Converting enzyme inhibition in chronic renal failure

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0069-4

Beta blockers in the management of chronic kidney disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0069-4

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

21 January 2018

1 reference

12 December 2020

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

1 reference

12 December 2020

Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action

1 reference

12 December 2020

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis

1 reference

12 December 2020

The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease

1 reference

12 December 2020

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

1 reference

12 December 2020

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

12 December 2020

Aldosterone in chronic kidney and cardiac disease

1 reference

12 December 2020

USRDS: the United States Renal Data System

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent

1 reference

12 December 2020

Calcium channel antagonists: clinical uses--past, present and future

1 reference

12 December 2020

Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study

1 reference

12 December 2020

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

12 December 2020

Successful blood pressure control in the African American Study of Kidney Disease and Hypertension

1 reference

12 December 2020

The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study

1 reference

12 December 2020

Protecting renal function in the hypertensive patient: clinical guidelines

1 reference

12 December 2020

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

12 December 2020

Preventing microalbuminuria in type 2 diabetes

1 reference

12 December 2020

Effect of long-term carvedilol therapy on renal function in essential hypertension

1 reference

12 December 2020

Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease

1 reference

12 December 2020

Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis

1 reference

12 December 2020

Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy

1 reference

12 December 2020

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

12 December 2020

Functional renin receptors in renal mesangial cells

1 reference

12 December 2020

Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

1 reference

12 December 2020

Differential effects of calcium antagonist subclasses on markers of nephropathy progression

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats

1 reference

12 December 2020

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.

1 reference

12 December 2020

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

1 reference

12 December 2020

Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats

1 reference

12 December 2020

Calcium channel blockers, endothelial dysfunction, and combination therapy.

1 reference

12 December 2020

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

1 reference

12 December 2020

Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers

1 reference

12 December 2020

Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes

1 reference

12 December 2020

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-007-0069-4

Identifiers

DOI

1 reference

17 August 2017

1 reference